Complications and mortality after catheter ablation of ventricular arrhythmias: risk in VT ablation (RIVA) score

• Published in: Clinical research in cardiology 2022-05, Vol.111 (5), p.530-540
• Main Authors: Mathew, Shibu, Fink, Thomas, Feickert, Sebastian, Inaba, Osamu, Hashiguchi, Naotaka, Schlüter, Michael, Wohlmuth, Peter, Wissner, Erik, Tilz, Roland Richard, Heeger, Christian-Hendrik, Rottner, Laura, Reissmann, Bruno, Rillig, Andreas, Metzner, Andreas, Maurer, Tilman, Kuck, Karl-Heinz, Ouyang, Feifan
• Format: Article
• Language: English
• Subjects: Ablation; Anticoagulants; Arrhythmia; Arrhythmias, Cardiac - etiology; Cardiac arrhythmia; Cardiac Tamponade - etiology; Cardiology; Cardiovascular disease; Cardiovascular diseases; Catheter Ablation - methods; Catheters; Complications; Coronary artery disease; Factor analysis; Heart; Heart diseases; Heart surgery; Humans; Ischemia; Medical instruments; Medicine; Medicine & Public Health; Mortality; Original Paper; Patients; Prophylaxis; Radiofrequency ablation; Regression models; Risk analysis; Risk assessment; Risk Factors; Safety; Tachycardia, Ventricular; Tamponade; Treatment Outcome; Ventricle
• ISSN: 1861-0684; 1861-0692; 1861-0692
• DOI: 10.1007/s00392-021-01902-2

Aims Catheter ablation of ventricular arrhythmias (VA) has proven to be an effective therapeutic option for secondary arrhythmia prophylaxis. We sought to assess the procedural efficacy, safety and in-hospital mortality of a large patient cohort with and without structural heart disease undergoing VA ablation. Methods A total of 1417 patients (804 patients with structural heart disease) undergoing 1792 endo- and epicardial procedures were analyzed. Multivariable risk factor analysis for occurrence of major complications and intrahospital mortality was obtained and a score to allow preprocedural risk assessment for patients undergoing VA ablation procedures was established. Results Major complication occurred in 4.4% of all procedures and significantly more often in patients with structural heart disease than in structurally normal hearts (6.0 vs. 1.8%). The frequency of these periprocedural complications was significantly different between procedures with sole right ventricular and a combination of RV and LV access (0.5 vs. 3.1%). The most common complication was cardiac tamponade in 46 cases (3.0%). Intrahospital death was observed in 32 patients (1.8%). Logistic regression model revealed presence of ischemic heart disease, epicardial ablation, presence of oral anticoagulation or dual antiplatelet therapy as independent risk factors for the occurrence of complications or intrahospital death, while a history of previous heart surgery was an independent predictor with a decreased risk. Based on this analysis a risk score incorporating 5 standard variables was established to predict the occurrence of complications and intrahospital mortality. Conclusions Safety of VA catheter ablation mainly relies on patient baseline characteristics and the type of access into the ventricles or epicardial space.